Semaglutide Nasal Spray(Shanghai World Ling Pharma)

司美格鲁肽鼻喷雾剂（上海世领制药）

Report date: 2026/01/12 15:20:15

Base Information

Drug NameSemaglutide Nasal Spray(Shanghai World Ling Pharma)
Drug Alias Name司美格鲁肽鼻喷雾剂（2.2类改良型）
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai World Ling Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai World Ling Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A